Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis.

Fiche du document

Auteurs
Type de document
Périmètre
Langue
Identifiants
Source

Serveur académique Lausannois

Relations

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.jhep.2020.06.021

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/32585161

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/eissn/1600-0641

Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_B2C6A0D6E0071

Collection

Serveur Académique Lausannois

Organisation

Université de Lausanne et CHUV

Licences

info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer

Mots-clés 0

Betacoronavirus/isolation & purification; COVID-19; Coronavirus Infections/diagnosis; Coronavirus Infections/physiopathology; Diagnosis, Differential; Fibrinogen/analysis; Glycogen Storage Disease Type IV/diagnosis; Hepatitis/etiology; Hepatitis/pathology; Hepatitis/physiopathology; Hepatitis B, Chronic/diagnosis; Humans; Inclusion Bodies/pathology; Lafora Disease/diagnosis; Liver/diagnostic imaging; Liver/pathology; Liver Function Tests/methods; Male; Middle Aged; Pandemics; Patient Care Management/methods; Pneumonia, Ventilator-Associated/therapy; Pneumonia, Viral/diagnosis; Pneumonia, Viral/physiopathology; Pulmonary Embolism/diagnosis; Pulmonary Embolism/etiology; Pulmonary Embolism/physiopathology; Respiration, Artificial/adverse effects; Respiration, Artificial/methods; SARS-CoV-2; Treatment Outcome

Sujets proches En

Pneumonitis Lungs--Inflammation

Citer ce document

M. Fraga et al., « Hepatocellular type II fibrinogen inclusions in a patient with severe COVID-19 and hepatitis. », Serveur académique Lausannois, ID : 10.1016/j.jhep.2020.06.021

Métriques

Partage / Export

document thumbnail

Par les mêmes auteurs

Sur les mêmes sujets

Exporter en